{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-048401","form_type":"8-K","ticker":"IPI","cik":"0001421461","company_name":"Intrepid Potash, Inc.","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.344363+00:00","generated_at":"2026-06-03T21:37:38.893990+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CEO Bob Jornayvaz takes medical leave; CFO Matt Preston appointed acting CEO; co-founder Hugh Harvey rejoins board","bullets":["CEO Bob Jornayvaz granted temporary medical leave effective April 16, 2024, to recover from previously announced accident.","CFO Matt Preston appointed acting principal executive officer; will continue as CFO and receive additional $50,000/month.","Chairman duties temporarily delegated to Lead Director Barth Whitham.","Board expanded to 7 directors; co-founder Hugh Harvey appointed Class III director, effective immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-048401","json":"https://secwatch.observer/filing/0001104659-24-048401.json","markdown":"https://secwatch.observer/filing/0001104659-24-048401.md","text":"https://secwatch.observer/filing/0001104659-24-048401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1421461/000110465924048401/0001104659-24-048401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1421461/000110465924048401/tm2412043d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:37:38.893990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"097972256d","claim":"Matthew D. Preston was appointed as acting principal executive officer at Intrepid Potash, Inc..","evidence_excerpt":"the Board appointed Matthew D. Preston, the Company’s Chief Financial Officer, as acting principal executive officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1421461/000110465924048401/0001104659-24-048401-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"acting principal executive officer"}],"fact_type":"executive_change"},{"claim_id":"92d0f61260","claim":"Hugh E. Harvey, Jr. was appointed as Class III director at Intrepid Potash, Inc..","evidence_excerpt":"appointed Hugh E. Harvey, Jr. to serve as a Class III director on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1421461/000110465924048401/0001104659-24-048401-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"},{"claim_id":"a4f130ca0c","claim":"Barth Whitham changed role as Lead Director (acting Chairman) at Intrepid Potash, Inc..","evidence_excerpt":"the Board temporarily delegated all responsibilities of the Chairman of the Board to Barth Whitham, Lead Director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1421461/000110465924048401/0001104659-24-048401-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Action","value":"delegated chairman responsibilities"},{"label":"Role","value":"Lead Director (acting Chairman)"}],"fact_type":"executive_change"},{"claim_id":"df716fbab6","claim":"Robert P. Jornayvaz III changed role as Executive Chairman and Chief Executive Officer at Intrepid Potash, Inc..","evidence_excerpt":"granted Robert P. Jornayvaz III, Executive Chairman of the Board and Chief Executive Officer of the Company, a temporary medical leave of absence, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1421461/000110465924048401/0001104659-24-048401-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"granted a temporary medical leave of absence"},{"label":"Role","value":"Executive Chairman and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}